PCA Rx Partners With Cost Plus Drugs to Bring Transparency to Drug Pricing

Pharmacy benefit manager PCA Rx recently announced a collaboration with Mark Cuban Cost Plus Drug Company to offer employers and members clarity and openness in drug pricing in an industry known for hidden costs.

“We are excited to join forces with a like-minded company such as PCA Rx,” said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. “At Cost Plus Drugs, we are committed to revolutionizing the pharmaceutical landscape through transparent drug pricing and working with PCA Rx aligns seamlessly with our mission. Together, we are ensuring affordability, accessibility, and clarity in medication costs, empowering individuals to make informed choices about their health and well-being.”

The Mark Cuban Cost Plus Drug Company is a public-benefit corporation that transparently charges a standard markup on every prescription product it sells. The costplusdrugs.com online pharmacy launched in January 2022 now carries over 1000 prescription medications.

“PCA Rx and Cost Plus Drugs are committed to lowering drug prices and enhancing transparency, empowering individuals and employers to make informed health care decisions,” said Kelly Cromer, PharmD, vice president of operations and clinical at PCA Rx. “PCA Rx is committed to member access through all avenues to affordable medications. Together, we’re reshaping the future of accessible and affordable health care.”

Reference

Mark Cuban Cost Plus Drug Company teams up with PBM PCA Rx. News release. PCA Rx; December 18, 2023. Accessed December 26, 2023.